Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL30995237 | 0.94 | — | — | |
| Bicarbonate SCHEMBL3237788 | 0.94 | — | — | |
| Bicarbonate SCHEMBL40504 | 0.94 | CA4 (0.50) | — | |
| Bicarbonate SCHEMBL14562672 | 0.89 | CA4 (0.39) | — | |
| Bicarbonate SCHEMBL23086807 | 0.88 | — | — | |
| Bicarbonate SCHEMBL20422065 | 0.88 | — | — | |
| Bicarbonate SCHEMBL72939 | 0.88 | CA4 (0.46) | — | |
| Bicarbonate SCHEMBL489862 | 0.88 | CA4 (0.46) | — | |
| Bicarbonate SCHEMBL22476039 | 0.88 | CA4 (0.46) | — | |
| Bicarbonate SCHEMBL950160 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600633-B2 | Nanostructured carbons and methods of preparing the same | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2026-04-14 | — | — | US | claimed |
| EP-4633381-A1 | COMPOSTIONS FOR USE IN THE PROPHYLACTIC TREATMENT OF HYPOCALCEMIA IN A RUMINANT ANIMAL | Vilofoss A/S (DK) | 2025-10-22 | — | — | EP | claimed |
| CN-119666896-A | Quantitative determination method for two impurities of basic lanthanum carbonate in raw material drug lanthanum carbonate octahydrate | 上海明捷医药科技有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-118619327-A | Lanthanum carbonate hydroxide, preparation method thereof, lanthanum oxide and catalyst | 武汉大学 | 2024-09-10 | — | — | CN | claimed |
| WO-2024125758-A1 | COMPOSTIONS FOR USE IN THE PROPHYLACTIC TREATMENT OF HYPOCALCEMIA IN A RUMINANT ANIMAL | VILOFOSS A/S (DK) | 2024-06-20 | — | — | WO | claimed |
| CN-116443913-B | Controllable preparation method of superfine lanthanum oxide | 江苏国盛新材料有限公司 | 2023-12-08 | — | — | CN | claimed |
| CN-116969439-A | Method for constructing lanthanum carbonate hydroxide on surface of biochar and application of method | 农业农村部成都沼气科学研究所 | 2023-10-31 | — | — | CN | claimed |
| CN-116789161-A | Preparation method of high-purity basic lanthanum carbonate | 内蒙古中科蒙稀新材料有限责任公司 | 2023-09-22 | — | — | CN | claimed |
| CN-116443913-A | Controllable preparation method of superfine lanthanum oxide | 江苏国盛新材料有限公司 | 2023-07-18 | — | — | CN | claimed |
| CN-111792672-B | Branch cross-linked coralline micron-structured lithium-containing oxide powder material and preparation method thereof | 浙江锋锂新能源科技有限公司 | 2022-09-06 | — | — | CN | claimed |
| CN-111792672-A | Branch cross-linked coralline micron-structured lithium-containing oxide powder material and preparation method thereof | 浙江锋锂新能源科技有限公司 | 2020-10-20 | — | — | CN | claimed |
| CN-110579499-A | Method for detecting lanthanum carbonate or lanthanum hydroxycarbonate impurity in preparation thereof | 北京华睿鼎信科技有限公司 | 2019-12-17 | — | — | CN | claimed |
| US-8961917-B2 | Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use | SPECTRUM PHARMACEUTICALS, INC. (US) | 2015-02-24 | — | — | US | claimed |
| EP-2568989-A1 | LANTHANUM CARBONATE HYDROXIDE, LANTHANUM OXYCARBONATE AND METHODS OF THEIR MANUFACTURE AND USE | Spectrum Pharmaceuticals, Inc. (US) | 2013-03-20 | — | — | EP | claimed |
| US-20110280956-A1 | LANTHANUM CARBONATE HYDROXIDE, LANTHANUM OXYCARBONATE AND METHODS OF THEIR MANUFACTURE AND USE | SPECTRUM PHARMACEUTICALS, INC. (US) | 2011-11-17 | — | — | US | claimed |
| WO-2011143475-A1 | LANTHANUM CARBONATE HYDROXIDE, LANTHANUM OXYCARBONATE AND METHODS OF THEIR MANUFACTURE AND USE | SPECTRUM PHARMACEUTICALS, INC. (US) | 2011-11-17 | — | — | WO | claimed |
| EP-1947960-A4 | HYPERPHOSPHATEMIA IN DOMESTIC ANIMALS: COMPOSITIONS AND METHODS OF TREATMENT | ALTAIRNANO INC (US) | 2009-05-06 | — | — | EP | claimed |
| EP-1947960-A2 | HYPERPHOSPHATEMIA IN DOMESTIC ANIMALS: COMPOSITIONS AND METHODS OF TREATMENT | Altairnano, Inc (US) | 2008-07-30 | — | — | EP | claimed |
| US-20080069860-A1 | Administering a rare earth compound with calcium and aluminum salt or hydrophilic exchange resin in foods | SPECTRUM PHARMACEUTICALS, INC. | 2008-03-20 | — | — | US | claimed |
| WO-2007022466-A2 | HYPERPHOSPHATEMIA IN DOMESTIC ANIMALS: COMPOSITIONS AND METHODS OF TREATMENT | ALTAIRNANO, INC. (US) | 2007-02-22 | — | — | WO | claimed |